The interaction of plasminogen with the cell surface: involvement of plasminogen binding and activation during cell death

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system

  1999cited by this paper
• The Role of the Plasminogen Activation System in Cancer

  1999cited by this paper
• Role of proteases in implantation.

  1999cited by this paper
• Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model.

  1999cited by this paper
• Localization of plasminogen activator inhibitor type 2 (PAI-2) in hair and nail: implications for terminal differentiation.

  1998cited by this paper
• The Serine Proteinase Inhibitor (Serpin) Plasminogen Activation Inhibitor Type 2 Protects against Viral Cytopathic Effects by Constitutive Interferon α/β Priming

  1998cited by this paper
• Activation of Matrix Metalloproteinases in Preterm Infant Lung † 1730

  1998cited by this paper
• Microglial cells prevent nitric oxide‐induced neuronal apoptosis in vitro

  1998cited by this paper
• The Jak/Stat Pathway and Urokinase Receptor Signaling in Human Aortic Vascular Smooth Muscle Cells*

  1998cited by this paper
• Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor alpha (TNF-alpha).

  1998cited by this paper
• Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.

  1998cited by this paper
• Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice

  1998cited by this paper
• Thrombin Perturbs Neurite Outgrowth and Induces Apoptotic Cell Death in Enriched Chick Spinal Motoneuron Cultures through Caspase Activation

  1998cited by this paper
• Urokinase Receptor (CD87) Regulates Leukocyte Recruitment via β2 Integrins In Vivo

  1998cited by this paper
• Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins.

  1998cited by this paper
• Nuclear targeting of the serine protease granzyme A (fragmentin-1).

  1998cited by this paper
• Tissue‐type plasminogen activator is not required for kainate‐induced motoneuron death in vitro

  1998cited by this paper
• Molecular Co-operation between Protein PAM and Streptokinase for Plasmin Acquisition by Streptococcus pyogenes *

  1998cited by this paper
• Plasminogen Binding and Activation at the Surface of Helicobacter pylori CCUG 17874

  1998cited by this paper
• Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes.

  1998cited by this paper
• Vitronectin Concentrates Proteolytic Activity on the Cell Surface and Extracellular Matrix by Trapping Soluble Urokinase Receptor-Urokinase Complexes

  1998cited by this paper
• Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis.

  1997cited by this paper
• Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice.

  1997cited by this paper
• An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus

  1997cited by this paper
• Urokinase‐mediated transactivation of the plasminogen activator inhibitor type 2 (PAI‐2) gene promoter in HT‐1080 cells utilises AP‐1 binding sites and potentiates phorbol ester‐mediated induction of endogenous PAI‐2 mRNA

  1997cited by this paper
• Vascular smooth muscle cells potentiate plasmin generation by both urokinase and tissue plasminogen activator-dependent mechanisms: evidence for a specific tissue-type plasminogen activator receptor on these cells.

  1997cited by this paper
• Identification of an Epitope of α-Enolase (a Candidate Plasminogen Receptor) by Phage Display

  1997cited by this paper
• Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.

  1997cited by this paper
• Expression of avian urokinase and tissue-type plasminogen activator messenger ribonucleic acid during follicle development and atresia.

  1997cited by this paper
• Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.

  1997cited by this paper
• Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice

  1997cited by this paper
• Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice.

  1997cited by this paper
• Complement C5b-9 increases plasminogen binding and activation on human endothelial cells.

  1997cited by this paper
• Thrombin generation by apoptotic vascular smooth muscle cells.

  1997cited by this paper
• Quantitative assessment of interaction of urokinase-type plasminogen activator and its receptor (CD87) by use of a solid-phase uPA-ligand binding assay

  1997cited by this paper
• Enhancement of plasminogen binding and fibrinolysis by chloropeptin I.

  1997cited by this paper
• Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin.

  1997cited by this paper
• Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation.

  1996cited by this paper
• Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysis.

  1996cited by this paper
• The urokinase receptor is a major vitronectin-binding protein on endothelial cells.

  1996cited by this paper
• Effect of Lipoprotein(a) and LDL on Plasminogen Binding to Extracellular Matrix and on Matrix-dependent Plasminogen Activation by Tissue Plasminogen Activator

  1996cited by this paper
• Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.

  1996cited by this paper
• Isolation and characterization of tissue-type plasminogen activator- binding proteoglycans from human umbilical vein endothelial cells.

  1996cited by this paper
• Defensin Modulates Tissue-type Plasminogen Activator and Plasminogen Binding to Fibrin and Endothelial Cells*

  1996cited by this paper
• Multiple pathways for apoptotic nuclear fragmentation.

  1996cited by this paper
• Diverse molecular provocation of programmed cell death.

  1996cited by this paper
• Integrins as promiscuous signal transduction devices.

  1996cited by this paper
• Binding of human plasminogen and lactoferrin by Helicobacter pylori coccoid forms.

  1996cited by this paper
• Angiostatin induces and sustains dormancy of human primary tumors in mice

  1996cited by this paper
• Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies

  1996cited by this paper
• Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell Migration*

  1996cited by this paper
• Proteolytic cleavage of the urokinase receptor substitutes for the agonist‐induced chemotactic effect.

  1996cited by this paper
• The role of proteases during apoptosis

  1996cited by this paper
• Mutation of lysines in a plasminogen binding region of streptokinase identifies residues important for generating a functional activator complex.

  1996cited by this paper
• ENDOTHELIAL CELL SURFACE ACTIN SERVES AS A BINDING SITE FOR PLASMINOGEN, TISSUE PLASMINOGEN ACTIVATOR AND LIPOPROTEIN(a)

  1996cited by this paper
• Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells

  1996cited by this paper
• The plasminogen activation system and its role in lung cancer. A review.

  1995cited by this paper
• Complement component C7 is a plasminogen-binding protein.

  1995cited by this paper
• Binding of plasminogen to corneal fibroblasts and their extracellular matrix. Evidence for a receptor in cell membranes

  1995cited by this paper
• Structural domains of streptokinase involved in the interaction with plasminogen.

  1995cited by this paper
• Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

  1995cited by this paper
• Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium.

  1995cited by this paper
• Perforin: structure and function.

  1995cited by this paper
• Protease activation during apoptosis: death by a thousand cuts?

  1995cited by this paper
• THP‐1 macrophage membrane‐bound plasmin activity is up‐regulated by transforming growth factor‐β1 via increased expression of urokinase and the urokinase receptor

  1995cited by this paper
• Identification of a plasminogen‐binding motif in PAM, a bacterial surface protein

  1995cited by this paper
• A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines.

  1995cited by this paper
• alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)- dependent internalization of the urokinase receptor

  1995cited by this paper
• The Activation of Type 1 and Type 2 Plasminogen by Type I and Type II Tissue Plasminogen Activator (*)

  1995cited by this paper
• Biological and clinical aspects of plasminogen activator inhibitor type 2.

  1995cited by this paper
• The role of an enolase-related molecule in plasminogen binding to cells.

  1995cited by this paper
• Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers

  1995cited by this paper
• Identification of an Inhibitor of Tissue-type Plasminogen Activator-mediated Fibrinolysis in Human Neutrophils

  1995cited by this paper
• Granzyme A is an interleukin 1 beta-converting enzyme

  1995cited by this paper
• Urokinase plasminogen activator receptor, beta 2-integrins, and Src- kinases within a single receptor complex of human monocytes

  1995cited by this paper
• Vascular Endothelial Growth Factor Increases Urokinase Receptor Expression in Vascular Endothelial Cells (*)

  1995cited by this paper
• Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix

  1995cited by this paper
• Inhibition of metastasis of lewis lung carcinoma by a synthetic peptide within growth factor‐like domain of urokinase in the experimental and spontaneous metastasis model

  1994cited by this paper
• Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis.

  1994cited by this paper
• Surface-associated plasminogen activation in leukemic cells: interaction with extracellular matrix.

  1994cited by this paper
• The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor.

  1994cited by this paper
• Thrombospondin (TSP) and transforming growth factor beta 1 (TGF-beta) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) production and stimulate tumor cell attachment in vitro.

  1994cited by this paper
• Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells.

  1994cited by this paper
• Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer.

  1994cited by this paper
• Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells

  1994cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• Binding of vitronectin and plasminogen to Helicobacter pylori.

  1994cited by this paper
• Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes.

  1994cited by this paper
• PAI-1 released from cultured human endothelial cells delays fibrinolysis and is incorporated into the developing fibrin clot*

  1994cited by this paper
• Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937.

  1994cited by this paper
• Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells

  1994cited by this paper
• Gene regulation of interleukin-1 beta, interleukin-1 receptor type I, and plasminogen activator inhibitor-1 and -2 in human granulosa-luteal cells.

  1994cited by this paper
• Binding of tissue-type plasminogen activator (t-PA) to Neisseria meningitidis and Haemophilus influenzae.

  1994cited by this paper
• Comparison of plasminogen binding and activation on extracellular matrices produced by vascular smooth muscle and endothelial cells.

  1994cited by this paper
• Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein

  1994cited by this paper
• Kinetics and mechanism of platelet-surface plasminogen activation by tissue-type plasminogen activator.

  1994cited by this paper
• Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.

  1994cited by this paper
• Characterization of the interaction between plasminogen and staphylokinase.

  1994cited by this paper
• Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor.

  1994cited by this paper
• Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces.

  1994cited by this paper

• No citing papers are available for this paper.